Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Hepatol. Sep 28, 2016; 8(27): 1137-1148
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1137
Table 1 Characteristics of the study groups at baseline (pre-intervention) and after 6 mo of energy restriction or exercise training (post-intervention)
Energy restriction (n = 6)
Exercise training (n = 10)
PrePostPrePost
Age (yr)45.5 ± 13.551.8 ± 6.7
Gender (M:F)3:37:3
BMI (kg/m2)33.5 ± 9.030.0 ± 7.0a31.2 ± 3.230.8 ± 3.5
Fat-mass (%)38 ± 935 ± 11b36 ± 733 ± 6a
Fat-free mass (kg)54.1 ± 12.351.3 ± 11.863.1 ± 14.364.4 ± 14.2a
Waist (cm)106 ± 1690 ± 13110 ± 14105 ± 13a
Systolic blood pressure (mmHg)126 ± 13118 ± 13a139 ± 19137 ± 18
Subcutaneous adipose tissue (cm2)358 ± 282268 ± 202b322 ± 116298 ± 117a
Visceral adipose tissue (cm2)202 ± 110203 ± 56b182 ± 67117 ± 36a
Diastolic blood pressure (mmHg)83 ± 875 ± 1288 ± 1183 ± 10
Triglycerides (mmol/L)1.6 ± 0.81.1 ± 0.42.0 ± 1.32.0 ± 0.2
HDL cholesterol (mmol/L)0.9 ± 0.21.0 ± 0.31.0 ± 0.21.1 ± 0.2a
LDL cholesterol (mmol/L)3.5 ± 0.83.0 ± 0.63.2 ± 1.13.1 ± 1.0
VLDL cholesterol (mmol/L)0.7 ± 0.30.5 ± 0.2b0.9 ± 0.60.7 ± 0.5
Free fatty acids (mmol/L)0.59 ± 0.150.63 ± 0.230.59 ± 0.170.62 ± 0.25
Glucose (mmol/L)5.2 ± 0.35.0 ± 0.75.5 ± 0.55.3 ± 0.4
Insulin (mU/L)18 ± 1810 ± 524 ± 2312 ± 10
M-value (mg/kgFFM per minute)4.2 ± 1.45.2 ± 1.54.0 ± 0.95.2 ± 1.6a
hsCPR (mg/L)4.9 ± 3.72.0 ± 1.63.9 ± 3.61.5 ± 1.3
Alanine aminotransferase (U/L80 ± 6555 ± 5554 ± 1949 ± 28
Aspartate aminotransferase (U/L)40 ± 2228 ± 1638 ± 1139 ± 22
Table 2 Resting substrate metabolism pre-intervention and after 6 mo of energy restriction or exercise training (post-intervention) in patients with non-alcoholic fatty liver disease
Energy restriction (n = 6)
Exercise (n = 10)
PrePostPPrePostP
Respiratory quotient0.82 ± 0.040.80 ± 0.040.380.84 ± 0.060.81 ± 0.060.05
Fatox (mg/kgFFM per minute)1.18 ± 0.251.46 ± 0.330.171.15 ± 0.541.35 ± 0.480.08
CHOox (mg/kgFFM per minute)2.33 ± 0.691.72 ± 0.830.192.70 ± 1.241.90 ± 1.170.02
Table 3 Change in substrate metabolism from basal (resting and fasting) to insulin-stimulation conditions pre-intervention and after 6 mo of energy restriction or exercise training (post-intervention)
Energy restriction (n = 6)
Exercise (n = 10)
PrePostPPrePostP
Δ Respiratory quotient0.05 ± 0.050.08 ± 0.050.580.04 ± 0.020.07 ± 0.050.11
Δ Fatox (mg/kgFFM per minute)-0.29 ± 0.46-0.56 ± 0.320.31-0.24 ± 0.36-0.55 ± 0.350.06
Δ CHOox (mg/kgFFM per minute)0.92 ± 0.981.41 ± 0.980.460.54 ± 0.851.02 ± 0.930.18
Table 4 Maximal aerobic power and substrate oxidation during exercise pre-intervention, and after 6 mo of energy restriction or exercise treatment (post-intervention)
Energy restriction (n = 6)
Exercise (n = 10)
PrePostPPrePostP
VO2peak (mL/kg per minute)20.4 ± 5.120.7 ± 6.40.7323.9 ± 6.428.3 ± 6.3< 0.001
VO2peak (mL/kgFFM per minute)32.5 ± 5.031.0 ± 5.40.3139.2 ± 8.443.6 ± 7.40.004
Workload at VO2peak (W)121 ± 53121 ± 570.94176 ± 78224 ± 81< 0.001
MFO (g/min)0.14 ± 0.130.06 ± 0.040.170.17 ± 0.090.29 ± 0.140.03
MFO (mg/kgFFM per minute)2.5 ± 1.71.2 ± 0.70.182.8 ± 1.54.4 ± 1.90.04
Workload at MFO (W)44.8 ± 16.541.3 ± 13.40.4344.7 ± 19.576.3 ± 46.00.03
Fatmax (%VO2peak)48.7 ± 14.747.9 ± 8.80.6245.2 ± 12.347.0 ± 7.20.94